Smriti Rajesh Agrawal is registered with Ministry of Corporate Affairs (MCA). Their DIN is 00075064. Following is their current and past directorship holdings.
Company |
Designation |
Original Date of Appointment |
|
|---|---|---|---|
ANVAXX LABORATORIES LLP |
Designated Partner |
01 June 2016 |
|
RITEAID ENTERPRISES LLP |
Designated Partner |
24 October 2019 |
|
GENCREST PRIVATE LIMITED |
Director |
18 December 2013 |
|
VETRIUM HEALTH PRIVATE LIMITED |
Director |
18 December 2013 |
|
SWADESH CAPITAL PRIVATE LIMITED |
Director |
01 February 2018 |
|
RITEAID FINANCE PRIVATE LIMITED |
Director |
01 February 2018 |
|
ALMIRON PRIVATE LIMITED |
Director |
08 January 2018 |
|
AXERA ENTERPRISES PRIVATE LIMITED |
Director |
09 March 2018 |
|
NUVENTA PHARMA LLP |
Designated Partner |
28 May 2016 |
|
CDC PHARMA LLP |
Designated Partner |
28 May 2016 |
|
RENAMAX LABS LLP |
Designated Partner |
01 June 2016 |
|
ANSCA DERMACEUTICALS LLP |
Designated Partner |
01 June 2016 |
|
ILLUMA OPTHALMACEUTICALS LLP |
Designated Partner |
01 June 2016 |
|
ALMIRON PHARMA PRIVATE LIMITED |
Director |
18 December 2013 |
|
SUNCITY COMMODITIES PRIVATE LIMITED |
Director |
18 December 2013 |
|
AVECIA PHARMA PRIVATE LIMITED |
Director |
18 December 2013 |
|
GLEAMIO TRADING PRIVATE LIMITED |
Additional Director |
01 February 2013 |
|
ILLUMA OPTHALMACEUTICALS PRIVATE LIMITED |
Director |
18 December 2013 |
|
AVECIA PHARMA LLP |
Designated Partner |
28 May 2016 |
|
AUREUS PHARMA LLP |
Designated Partner |
28 May 2016 |
|
ZILLION LABS LLP |
Designated Partner |
01 June 2016 |
|
AXERA PHARMA LLP |
Designated Partner |
01 June 2016 |
|
VETRIUM HEALTH LLP |
Designated Partner |
01 June 2016 |
|
ALMIRON PHARMA LLP |
Designated Partner |
01 June 2016 |
|
AXERA PHARMA PRIVATE LIMITED |
Director |
18 December 2013 |
|
NUVENTA PHARMA PRIVATE LIMITED |
Director |
18 December 2013 |
|
SUNDER AJANTA INFRASTRUCTURES LIMITED |
Director |
17 July 2015 |
Company |
Designation |
Original Date of Appointment |
Date of Cessation |
|---|---|---|---|
Login to view this information. | |||